Raclopride
- Generic Name
- Raclopride
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H20Cl2N2O3
- CAS Number
- 84225-95-6
- Unique Ingredient Identifier
- 430K3SOZ7G
- Background
Raclopride has been used in trials studying Parkinson Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Phase 4
Recruiting
- Conditions
- PsychosisAnhedoniaDepression
- Interventions
- Drug: Matching Placebo PatchDrug: Transdermal EstradiolDrug: Raclopride C11Drug: Micronized Progesterone
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 103
- Registration Number
- NCT05282277
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease
Completed
- Conditions
- Parkinson DiseaseHealthy
- First Posted Date
- 2002-04-03
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Target Recruit Count
- 64
- Registration Number
- NCT00032812
- Locations
- 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath